Foghorn Therapeutics Inc.
Biotechnology ResearchView the employees at
Foghorn Therapeutics Inc.-
Sydney Blevins Scientist at Foghorn Therapeutics, Inc
-
Greater Boston
-
Rising Star
Mary-Margaret O'Donnell-Zablocki Principal Scientist Foghorn Therapeutics-
Cambridge, Massachusetts, United States
-
Rising Star
Liv Johannessen Associate Director @ Foghorn Therapeutics | Translational Medicine, Biomarkers-
United States
-
Top 5%
Jared Subiono Research Associate at Foghorn Therapeutics-
Boston, Massachusetts, United States
-
Rising Star
Ariel Lefkovith Manager, Translational Biomarker Operations at Foghorn Therapeutics Inc.-
Top 10%
Overview
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.
-